Nrf1 is targeted to the endoplasmic reticulum membrane by an N-terminal transmembrane domain. Inhibition of nuclear translocation and transacting function
about
Nrf2 and Nrf1 signaling and ER stress crosstalk: implication for proteasomal degradation and autophagyHuntingtin has a membrane association signal that can modulate huntingtin aggregation, nuclear entry and toxicityRole of Nrf1 in antioxidant response element-mediated gene expression and beyondRegulation of glutathione synthesisGlutathione synthesismTORC1 signaling activates NRF1 to increase cellular proteasome levelsIntegration of the unfolded protein and oxidative stress responses through SKN-1/NrfThe C-terminal domain of Nrf1 negatively regulates the full-length CNC-bZIP factor and its shorter isoform LCR-F1/Nrf1β; both are also inhibited by the small dominant-negative Nrf1γ/δ isoforms that down-regulate ARE-battery gene expressionThe p65 isoform of Nrf1 is a dominant negative inhibitor of ARE-mediated transcriptionTranscription factor Nrf1 negatively regulates the cystine/glutamate transporter and lipid-metabolizing enzymesDual regulation of the transcriptional activity of Nrf1 by β-TrCP- and Hrd1-dependent degradation mechanismsThe Fbw7 tumor suppressor regulates nuclear factor E2-related factor 1 transcription factor turnover through proteasome-mediated proteolysisNegative regulation of the Nrf1 transcription factor by its N-terminal domain is independent of Keap1: Nrf1, but not Nrf2, is targeted to the endoplasmic reticulumInduction of Herpud1 expression by ER stress is regulated by Nrf1The Nrf1 CNC-bZIP protein is regulated by the proteasome and activated by hypoxiaTranscription factor Nrf1 mediates the proteasome recovery pathway after proteasome inhibition in mammalian cellsGlycogen synthase kinase 3 regulates expression of nuclear factor-erythroid-2 related transcription factor-1 (Nrf1) and inhibits pro-survival function of Nrf1Long isoforms of NRF1 contribute to arsenic-induced antioxidant response in human keratinocytesNrf1 and Nrf2 play distinct roles in activation of antioxidant response element-dependent genesp97-dependent retrotranslocation and proteolytic processing govern formation of active Nrf1 upon proteasome inhibitionKeap1 controls postinduction repression of the Nrf2-mediated antioxidant response by escorting nuclear export of Nrf2Bioanalysis of eukaryotic organellesStress-activated cap'n'collar transcription factors in aging and human diseaseDietary chemoprevention strategies for induction of phase II xenobiotic-metabolizing enzymes in lung carcinogenesis: A reviewRegulation of proteasome activity in health and diseaseMechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative diseaseInhibitor of Nrf2 (INrf2 or Keap1) protein degrades Bcl-xL via phosphoglycerate mutase 5 and controls cellular apoptosisNrf2 and Nrf2-related proteins in development and developmental toxicity: Insights from studies in zebrafish (Danio rerio)Characterization of Nrf1b, a novel isoform of the nuclear factor-erythroid-2 related transcription factor-1 that activates antioxidant response element-regulated genesMCRS2 represses the transactivation activities of Nrf1.Regulation of clock-controlled genes in mammals.Cyanide-induced apoptosis of dopaminergic cells is promoted by BNIP3 and Bax modulation of endoplasmic reticulum-mitochondrial Ca2+ levels.Mechanisms and functions of Nrf2 signaling in Drosophila.The role of Nrf1 and Nrf2 in the regulation of glutathione and redox dynamics in the developing zebrafish embryoHypoxia is a Key Driver of Alternative Splicing in Human Breast Cancer Cells.PARK2/Parkin-mediated mitochondrial clearance contributes to proteasome activation during slow-twitch muscle atrophy via NFE2L1 nuclear translocation.NFE2L3 (NRF3): the Cinderella of the Cap'n'Collar transcription factors.NF-E2-related factor 1 (Nrf1) serves as a novel regulator of hepatic lipid metabolism through regulation of the Lipin1 and PGC-1β genesINrf2 (Keap1) targets Bcl-2 degradation and controls cellular apoptosis.Natural antioxidants exhibit chemopreventive characteristics through the regulation of CNC b-Zip transcription factors in estrogen-induced breast carcinogenesis
P2860
Q24296827-6AF69B2D-7837-402A-8FF8-7B966D42E679Q24337727-EF584746-C5F7-40E0-B6C5-EBE65ACC9134Q24629339-5E919FD4-B183-4061-8A3E-E15758D1101BQ24655260-A93A1D2C-5B46-498F-8C8D-A5397D66EA4EQ26864265-7423C862-D400-4172-9C3C-BDC3FF7A1658Q27012468-FD4D36DD-BE5D-469C-AD37-AEE81E2C10B0Q27320819-E9F7C31A-0980-410B-8C59-8F37D4800760Q27341433-D04801BC-5E4B-4DA5-B94F-FD10E0B3D0ACQ28235174-92FA1260-A1A1-421D-8F66-7C76A6443EA8Q28245245-85CC7EF2-59B2-4519-9AEC-E772BBFA6B4BQ28247844-91C28B55-1B7D-48EF-9C8E-CAB06239A8E8Q28249259-8A283C91-F01F-4387-B749-9648AD11142AQ28254462-0C38CC03-FE94-4460-8038-D9FEB6816B36Q28256252-21586047-A829-4872-A984-1A482C8B2A58Q28256645-46AEA988-D45A-4ABE-8D6E-D267F8039D6BQ28279454-D173CE4F-B446-4D25-AC9E-3B65B3E75F83Q28289761-A8D35C61-835D-4876-8B2A-BAE751033FCAQ28292085-C3A3FD40-B9D8-4B19-8840-02D8015C2819Q28295619-F0101E60-CDC5-4B8A-B569-19A79A7D54EAQ28306282-B93A10BB-8CAB-4E25-9CD6-52B9E4814B12Q28382872-2EFDA004-A24D-4116-9DD9-007D74B244D7Q28384122-6218B129-1840-4075-893F-67A2849665B0Q28384783-A1436C70-4E8B-404E-B4AB-991FE143643AQ28386665-01DAEA88-C9FD-4BBF-A743-EE9BDD903C95Q28392708-1160DA4E-5AFD-46B0-9786-10B9B4C09B20Q28394732-3DFCD11A-0D1F-423B-BFD1-04F22D28748FQ28395156-5D5BD5F2-66EB-436D-AF3E-B85895088FD2Q28398010-F56AD3ED-D3E7-4AED-85FF-0F15A278FE7CQ28587680-3E557A87-1294-40BC-BCB2-17EE100ACF0AQ33404881-A307F367-DABD-4D52-9974-17B1C37AFDF4Q33418304-7C4DD266-83EE-4489-B044-FE9BF07A7ADDQ33574880-2143C3DD-B411-4B2B-824C-3ED308246B55Q33763536-FFC4F591-518C-4AFA-9899-A0E63BC5E598Q33763635-D2E47EDB-0AEA-48A6-A56B-0FAD73E0CDC9Q33826009-E83A8C3C-C527-4711-A1CF-B8B0D9B44C1DQ33878865-821879CC-6073-43AD-9941-4242F0454862Q34193909-B6E05F28-2248-417E-807C-8D6D660DB4EEQ34274999-C6193D02-0A9D-4BC5-9696-7C7E29A8C640Q34441957-D1C5E347-7451-4810-9543-61A43A3C34D6Q34641803-F69F3AF6-45C3-46AD-9CD6-6FA6A5E5B835
P2860
Nrf1 is targeted to the endoplasmic reticulum membrane by an N-terminal transmembrane domain. Inhibition of nuclear translocation and transacting function
description
2006 nî lūn-bûn
@nan
2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Nrf1 is targeted to the endopl ...... ation and transacting function
@ast
Nrf1 is targeted to the endopl ...... ation and transacting function
@en
Nrf1 is targeted to the endopl ...... ation and transacting function
@nl
type
label
Nrf1 is targeted to the endopl ...... ation and transacting function
@ast
Nrf1 is targeted to the endopl ...... ation and transacting function
@en
Nrf1 is targeted to the endopl ...... ation and transacting function
@nl
prefLabel
Nrf1 is targeted to the endopl ...... ation and transacting function
@ast
Nrf1 is targeted to the endopl ...... ation and transacting function
@en
Nrf1 is targeted to the endopl ...... ation and transacting function
@nl
P2860
P3181
P356
P1476
Nrf1 is targeted to the endopl ...... ation and transacting function
@en
P2093
Jefferson Y Chan
Weiping Wang
P2860
P304
P3181
P356
10.1074/JBC.M602802200
P407
P577
2006-07-14T00:00:00Z